URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Ilan Goldenberg

Concepts (499)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Death, Sudden, Cardiac
43
1993
294
12.340
Why?
Defibrillators, Implantable
44
2005
418
11.760
Why?
Long QT Syndrome
31
2005
387
9.110
Why?
Heart Failure
30
1986
367
7.040
Why?
Cardiac Resynchronization Therapy
18
2010
89
6.790
Why?
Myocardial Infarction
30
1989
660
6.380
Why?
Risk Assessment
36
2003
884
4.290
Why?
Electrocardiography
35
1986
773
3.920
Why?
Ventricular Dysfunction, Left
16
2006
164
3.650
Why?
Bezafibrate
9
2004
9
3.580
Why?
Heart Arrest
17
1989
153
3.530
Why?
Risk Factors
56
1990
2345
3.270
Why?
Arrhythmias, Cardiac
12
1989
246
3.250
Why?
Syncope
19
1989
115
3.240
Why?
Mutation
12
2007
1216
3.200
Why?
Proportional Hazards Models
34
2003
450
3.120
Why?
Hypolipidemic Agents
8
2004
26
2.990
Why?
Female
133
1973
19838
2.900
Why?
Male
130
1986
19675
2.890
Why?
Adrenergic beta-Antagonists
18
1989
174
2.890
Why?
Aged
79
1973
7269
2.650
Why?
Humans
158
1973
36274
2.610
Why?
Coronary Artery Disease
10
1990
96
2.540
Why?
Genotype
21
2005
490
2.520
Why?
Genetic Predisposition to Disease
16
2005
331
2.440
Why?
Middle Aged
91
1973
9837
2.420
Why?
Kaplan-Meier Estimate
24
2007
222
2.340
Why?
Tachycardia, Ventricular
10
2006
156
2.320
Why?
KCNQ1 Potassium Channel
10
2007
76
2.310
Why?
Romano-Ward Syndrome
6
2007
37
2.240
Why?
Treatment Outcome
38
1994
2615
2.120
Why?
Coronary Disease
10
1989
258
2.080
Why?
Cholesterol, HDL
5
2005
62
1.980
Why?
Ventricular Remodeling
4
2010
38
1.900
Why?
Electric Countershock
8
1990
95
1.830
Why?
Acute Coronary Syndrome
3
2010
10
1.750
Why?
Follow-Up Studies
32
1974
1855
1.740
Why?
Cardiovascular Diseases
5
2006
277
1.700
Why?
Stroke Volume
13
1986
154
1.670
Why?
Heart Diseases
5
1989
142
1.640
Why?
Diabetic Angiopathies
2
2012
34
1.620
Why?
Prognosis
21
1964
1083
1.580
Why?
Ether-A-Go-Go Potassium Channels
5
2009
56
1.480
Why?
Survival Analysis
15
2006
606
1.470
Why?
Cardiomyopathies
6
2010
82
1.470
Why?
Survival Rate
16
1994
618
1.460
Why?
Multivariate Analysis
17
2003
541
1.440
Why?
Contrast Media
3
2004
267
1.430
Why?
Jervell-Lange Nielsen Syndrome
2
2006
11
1.360
Why?
Prospective Studies
20
1974
1689
1.320
Why?
Cause of Death
6
2006
162
1.300
Why?
Myocardial Ischemia
6
2003
118
1.290
Why?
Polymorphism, Genetic
4
2006
201
1.280
Why?
Time Factors
27
1973
3182
1.270
Why?
Recurrence
17
1989
691
1.240
Why?
Dyslipidemias
2
2008
13
1.230
Why?
Heart Conduction System
6
1989
153
1.200
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2012
48
1.190
Why?
Adult
54
1973
11351
1.170
Why?
Ventricular Fibrillation
7
1989
96
1.150
Why?
Adolescent
26
1986
4766
1.130
Why?
Blood Pressure
4
1989
467
1.120
Why?
Phenotype
12
2005
763
1.110
Why?
Acute Kidney Injury
2
2004
45
1.090
Why?
Genetic Testing
3
2008
96
1.090
Why?
Coronary Angiography
7
1989
85
1.070
Why?
Ion Channels
3
2008
153
1.060
Why?
Fibric Acids
2
2012
3
1.060
Why?
Bundle-Branch Block
6
2005
51
1.020
Why?
Glomerular Filtration Rate
6
2006
88
1.000
Why?
Child
19
1986
4155
0.990
Why?
Registries
13
2006
223
0.970
Why?
Incidence
12
2004
685
0.960
Why?
Child, Preschool
14
1989
2660
0.940
Why?
European Continental Ancestry Group
5
2006
234
0.920
Why?
Young Adult
12
2009
1059
0.920
Why?
Cardiovascular Agents
2
2010
22
0.910
Why?
Infant
13
1989
2278
0.890
Why?
Smoking
3
2004
399
0.880
Why?
Israel
8
2003
38
0.870
Why?
Genetic Association Studies
2
2011
19
0.860
Why?
Adamantane
1
2012
7
0.850
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2012
3
0.850
Why?
Pyrrolidines
1
2012
29
0.840
Why?
Kidney Diseases
3
2010
170
0.840
Why?
Nitriles
1
2012
40
0.840
Why?
Menopause
3
1964
43
0.820
Why?
Metformin
1
2012
30
0.820
Why?
Heart Rate
5
1989
461
0.810
Why?
African Continental Ancestry Group
3
2006
125
0.800
Why?
Atherosclerosis
1
2012
43
0.800
Why?
Coronary Care Units
1
2011
18
0.790
Why?
Diabetes Mellitus, Type 2
2
2004
224
0.790
Why?
Hypoglycemic Agents
1
2012
108
0.770
Why?
Thrombosis
2
1992
200
0.770
Why?
Sex Factors
6
2010
597
0.750
Why?
Patient Admission
1
2011
85
0.750
Why?
Age Distribution
6
2007
221
0.750
Why?
Myocardial Revascularization
2
2006
22
0.740
Why?
Sex Distribution
5
2007
160
0.720
Why?
Kidney Failure, Chronic
2
2007
122
0.720
Why?
Myocardium
7
1987
294
0.720
Why?
Angioplasty, Balloon, Coronary
6
1990
66
0.710
Why?
Patient Selection
2
2008
212
0.710
Why?
Research Design
1
2012
336
0.700
Why?
Renal Insufficiency
2
2005
21
0.690
Why?
Cardiomyopathy, Dilated
8
1989
42
0.680
Why?
Kidney
2
2005
586
0.670
Why?
Age of Onset
2
2007
126
0.660
Why?
Heterozygote
2
2007
125
0.660
Why?
Cholesterol, LDL
1
2008
28
0.650
Why?
Cardiac Pacing, Artificial
5
2008
158
0.650
Why?
Renal Insufficiency, Chronic
1
2008
14
0.650
Why?
Age Factors
9
1974
1128
0.640
Why?
Exercise
5
1989
182
0.630
Why?
Chi-Square Distribution
9
2006
344
0.620
Why?
Infant, Newborn
7
2007
1844
0.620
Why?
Decision Support Techniques
1
2008
74
0.610
Why?
Inflammation
1
2012
534
0.610
Why?
Cholesterol Ester Transfer Proteins
1
2007
15
0.610
Why?
Health Care Costs
2
2005
113
0.600
Why?
Echocardiography
10
1992
228
0.590
Why?
Atrial Fibrillation
3
1994
110
0.590
Why?
Severity of Illness Index
8
2007
922
0.580
Why?
Angiotensinogen
1
2006
8
0.570
Why?
DNA
1
2012
845
0.560
Why?
Smoking Cessation
2
2003
80
0.550
Why?
Risk
8
1982
368
0.550
Why?
Models, Economic
1
2005
28
0.520
Why?
Heart Valve Prosthesis
4
1991
40
0.520
Why?
Comorbidity
4
2004
380
0.520
Why?
Ventricular Function, Left
5
1990
95
0.490
Why?
Statistics, Nonparametric
5
2007
262
0.490
Why?
Tissue Plasminogen Activator
2
1989
52
0.480
Why?
Retrospective Studies
17
1986
2267
0.470
Why?
Free Radical Scavengers
1
2004
40
0.460
Why?
Acetylcysteine
1
2004
78
0.460
Why?
Clinical Trials as Topic
5
1989
671
0.450
Why?
Sodium Chloride
1
2004
121
0.450
Why?
Heart
2
1989
236
0.450
Why?
Adenosine
1
2003
86
0.440
Why?
Biological Markers
6
2008
560
0.440
Why?
Stents
2
2003
129
0.440
Why?
Hypertension
1
2006
301
0.430
Why?
Fibrinolytic Agents
1
2003
61
0.430
Why?
Angiotensin II
1
2003
122
0.420
Why?
Cohort Studies
9
1990
969
0.420
Why?
Hospital Mortality
5
2003
137
0.410
Why?
Mutation, Missense
4
2007
87
0.400
Why?
C-Reactive Protein
3
2009
122
0.400
Why?
Arrhythmogenic Right Ventricular Dysplasia
2
2011
20
0.390
Why?
Echocardiography, Doppler
2
1991
53
0.390
Why?
Aged, 80 and over
12
1989
2529
0.380
Why?
World Health
2
2011
63
0.380
Why?
Predictive Value of Tests
7
2005
606
0.360
Why?
Confidence Intervals
5
2007
165
0.360
Why?
Sodium Channels
2
2010
120
0.350
Why?
Cholesterol
3
2004
137
0.350
Why?
Hypertriglyceridemia
2
2006
24
0.350
Why?
Ion Channel Gating
2
2011
127
0.340
Why?
Uric Acid
2
2009
51
0.330
Why?
United States
8
2005
2688
0.330
Why?
Triglycerides
3
2005
104
0.320
Why?
Regression Analysis
3
2007
527
0.320
Why?
Double-Blind Method
4
1994
992
0.310
Why?
Exercise Test
4
1993
101
0.310
Why?
Hemodynamics
7
1986
272
0.310
Why?
Randomized Controlled Trials as Topic
5
2003
411
0.300
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2006
48
0.300
Why?
Apoptosis
1
2003
823
0.300
Why?
Myocardial Contraction
3
2011
111
0.290
Why?
Pacemaker, Artificial
2
2008
162
0.270
Why?
Cardiomyopathy, Hypertrophic
2
1993
16
0.260
Why?
Autoantibodies
7
1989
98
0.250
Why?
Diltiazem
1
1994
33
0.250
Why?
Probability
3
2007
302
0.250
Why?
Atrial Flutter
1
1994
25
0.240
Why?
Europe
2
2011
80
0.240
Why?
DNA Mutational Analysis
2
2011
189
0.240
Why?
Disease Progression
4
2004
521
0.240
Why?
Tachycardia
2
1989
67
0.230
Why?
Coronary Artery Bypass
2
1995
106
0.230
Why?
Heart Function Tests
2
1993
33
0.230
Why?
Coronary Restenosis
2
2002
6
0.230
Why?
Polymorphism, Single Nucleotide
3
2007
90
0.230
Why?
Diagnosis, Differential
3
2010
874
0.230
Why?
Sensitivity and Specificity
3
1991
905
0.220
Why?
Homocysteine
2
2002
28
0.220
Why?
Adiponectin
1
2012
5
0.210
Why?
Platelet Function Tests
1
2012
15
0.210
Why?
Pancreatitis
1
2012
29
0.210
Why?
Matrix Metalloproteinase 9
1
2012
58
0.210
Why?
Sequence Deletion
2
2007
129
0.210
Why?
Drug Combinations
1
2012
148
0.200
Why?
Atrial Function, Left
1
2011
4
0.200
Why?
Patient Readmission
1
2012
39
0.200
Why?
Endocardial Cushion Defects
1
2011
9
0.200
Why?
Brugada Syndrome
1
2011
3
0.200
Why?
Andersen Syndrome
1
2011
4
0.200
Why?
Precipitating Factors
1
2011
6
0.200
Why?
Thrombospondins
1
2011
13
0.200
Why?
Defibrillators
1
2011
6
0.200
Why?
Arteritis
1
2011
15
0.200
Why?
Aortic Valve Stenosis
1
2011
21
0.200
Why?
Analysis of Variance
3
2007
736
0.200
Why?
Atrioventricular Block
1
2011
6
0.200
Why?
Interleukin-1beta
1
2012
61
0.200
Why?
Mitral Valve Insufficiency
1
1991
24
0.200
Why?
Heart-Assist Devices
1
2011
34
0.200
Why?
Inflammation Mediators
1
2012
113
0.200
Why?
Down Syndrome
1
2011
42
0.200
Why?
Estrogen Replacement Therapy
1
2011
21
0.200
Why?
Health Status Disparities
1
2012
49
0.190
Why?
Cardiac Resynchronization Therapy Devices
1
2011
13
0.190
Why?
Sleep
1
2011
59
0.190
Why?
Heart Failure, Systolic
1
2010
3
0.190
Why?
Reproducibility of Results
2
2010
877
0.190
Why?
Pregnancy Complications, Cardiovascular
2
2007
38
0.190
Why?
Amino Acid Substitution
1
2011
124
0.190
Why?
Heart Defects, Congenital
1
2011
103
0.190
Why?
Blood Urea Nitrogen
1
2010
43
0.190
Why?
Siblings
1
2010
36
0.190
Why?
Potassium
2
1989
304
0.190
Why?
Brain Ischemia
1
2011
86
0.190
Why?
Creatinine
2
1974
127
0.190
Why?
Blood Volume
1
2010
53
0.190
Why?
Electrodes, Implanted
1
2011
57
0.190
Why?
Equipment Design
3
1989
248
0.190
Why?
Inpatients
1
2010
72
0.180
Why?
Receptors, Adrenergic, beta
4
1989
67
0.180
Why?
Arousal
1
2010
56
0.180
Why?
Cardiac Surgical Procedures
1
2011
80
0.180
Why?
Ambulatory Care
1
2011
156
0.180
Why?
Creatine Kinase
2
1986
53
0.180
Why?
Hospitalization
2
2008
399
0.180
Why?
Calcinosis
1
2010
63
0.180
Why?
Family
1
2011
201
0.180
Why?
Tricuspid Valve Stenosis
1
1989
2
0.180
Why?
Electrocardiography, Ambulatory
1
2010
93
0.170
Why?
Interleukin-6
1
2012
339
0.170
Why?
Stroke
1
2011
134
0.170
Why?
Receptors, Adrenergic
1
1989
28
0.170
Why?
Life Tables
2
2004
39
0.170
Why?
Dobutamine
1
1989
26
0.170
Why?
Needs Assessment
1
2010
95
0.160
Why?
Body Mass Index
1
2010
218
0.160
Why?
Prosthesis Design
4
1991
68
0.160
Why?
Catheterization
1
1989
125
0.160
Why?
Conserved Sequence
1
2009
103
0.160
Why?
Muscle Proteins
1
2010
142
0.160
Why?
Peroxisome Proliferator-Activated Receptors
1
2008
4
0.160
Why?
Diabetes Mellitus
1
2009
169
0.160
Why?
Morbidity
1
2008
75
0.160
Why?
Adrenergic beta-Agonists
1
2008
51
0.160
Why?
Asian Continental Ancestry Group
1
2008
30
0.160
Why?
Hypotension
4
1989
47
0.160
Why?
Homozygote
2
1995
97
0.160
Why?
Equipment Failure
1
2008
72
0.160
Why?
Genetic Variation
1
2008
151
0.150
Why?
Cost-Benefit Analysis
2
2005
215
0.150
Why?
Colonic Neoplasms
1
2008
124
0.150
Why?
African Americans
1
2010
219
0.150
Why?
Aryldialkylphosphatase
1
2007
6
0.150
Why?
Primary Prevention
1
2008
58
0.150
Why?
Pregnancy, High-Risk
1
2007
14
0.150
Why?
Lipids
1
2007
168
0.150
Why?
History, 20th Century
1
2008
244
0.140
Why?
Threonine
1
2006
29
0.140
Why?
Clofibric Acid
1
2006
6
0.140
Why?
Nitric Oxide Synthase Type III
1
2007
66
0.140
Why?
Methionine
1
2006
52
0.140
Why?
Gene Frequency
1
2006
88
0.140
Why?
Breast Neoplasms
6
1964
673
0.140
Why?
Clinical Enzyme Tests
1
1986
17
0.140
Why?
Electric Injuries
1
1986
6
0.140
Why?
Heart Injuries
1
1986
15
0.140
Why?
Military Personnel
2
2003
39
0.140
Why?
Hemorrhage
2
1989
180
0.130
Why?
Pregnancy Outcome
1
2007
137
0.130
Why?
Osmosis
1
2005
12
0.130
Why?
Mortality
1
2006
89
0.130
Why?
Serologic Tests
1
2005
24
0.130
Why?
Celiac Disease
1
2005
21
0.130
Why?
Platelet Aggregation Inhibitors
2
1990
61
0.130
Why?
Outcome Assessment (Health Care)
1
2008
301
0.130
Why?
Administration, Oral
2
1973
308
0.120
Why?
Reference Values
1
2006
439
0.120
Why?
Ticlopidine
1
2004
6
0.120
Why?
Logistic Models
2
2003
611
0.120
Why?
Prodrugs
1
2004
22
0.120
Why?
Asthma
1
2008
317
0.120
Why?
Glucose Intolerance
1
2004
25
0.120
Why?
DNA Damage
1
2005
170
0.120
Why?
Adenosine A3 Receptor Agonists
1
2003
1
0.120
Why?
Receptor, Adenosine A3
1
2003
2
0.120
Why?
Adenosine A1 Receptor Agonists
1
2003
5
0.120
Why?
Receptor, Adenosine A1
1
2003
9
0.120
Why?
Norepinephrine
3
1987
256
0.120
Why?
In Situ Nick-End Labeling
1
2003
94
0.110
Why?
Hematologic Tests
1
2003
9
0.110
Why?
Antioxidants
1
2005
205
0.110
Why?
Obesity
1
2007
339
0.110
Why?
Receptors, Cytoplasmic and Nuclear
1
2004
137
0.110
Why?
Anemia
1
2003
78
0.110
Why?
Maternal Age
1
1982
61
0.100
Why?
Drug Administration Schedule
1
2003
366
0.100
Why?
Carcinoma, Intraductal, Noninfiltrating
1
1982
40
0.100
Why?
Minnesota
2
2010
27
0.100
Why?
Bradycardia
3
1989
29
0.100
Why?
Heart Ventricles
3
1989
207
0.090
Why?
Heart Valve Diseases
3
1992
18
0.090
Why?
Rats, Sprague-Dawley
1
2003
986
0.090
Why?
Carcinoma
1
1982
191
0.090
Why?
Coronary Vessels
2
1989
132
0.090
Why?
Health Surveys
2
2010
215
0.090
Why?
Canada
2
2007
75
0.090
Why?
Heart Atria
3
1989
68
0.080
Why?
Prevalence
3
1993
562
0.080
Why?
Transcription Factors
1
2004
687
0.080
Why?
Codon, Nonsense
2
2007
56
0.080
Why?
Coronary Thrombosis
2
1990
11
0.080
Why?
Membrane Potentials
2
2007
340
0.070
Why?
Combined Modality Therapy
3
1990
486
0.070
Why?
Rats
2
1991
4289
0.070
Why?
Cells, Cultured
1
2003
2479
0.070
Why?
Posture
4
1989
110
0.070
Why?
Testolactone
2
1973
2
0.070
Why?
Calcium
1
2003
1083
0.070
Why?
Models, Molecular
2
2007
355
0.070
Why?
HLA-DQ Antigens
1
1995
5
0.070
Why?
Drug Therapy, Combination
2
2004
382
0.070
Why?
Isoproterenol
3
1989
74
0.070
Why?
Genes, MHC Class II
1
1995
31
0.060
Why?
Receptors, Interleukin-2
1
1995
30
0.060
Why?
Cardiac Tamponade
1
1995
13
0.060
Why?
Parity
2
1982
49
0.060
Why?
Injections, Intravenous
1
1994
131
0.060
Why?
Heart Transplantation
3
1987
71
0.060
Why?
Adenylate Cyclase
2
1990
39
0.060
Why?
Pregnancy
2
2007
1966
0.060
Why?
Androstanes
1
1973
1
0.060
Why?
Gallstones
1
2012
8
0.050
Why?
Animals
3
1991
16093
0.050
Why?
Confounding Factors (Epidemiology)
1
2012
61
0.050
Why?
Hyperlipidemias
1
2012
45
0.050
Why?
Cardiac Output
2
1986
112
0.050
Why?
Electrophysiologic Techniques, Cardiac
1
2012
24
0.050
Why?
Disease-Free Survival
1
2012
198
0.050
Why?
Thromboembolism
1
2011
41
0.050
Why?
Mitral Valve
1
1991
39
0.050
Why?
Cardiac Complexes, Premature
1
2011
12
0.050
Why?
Running
1
2011
14
0.050
Why?
Odds Ratio
1
2012
315
0.050
Why?
Prosthesis Failure
1
1991
86
0.050
Why?
Physical Exertion
1
2011
72
0.050
Why?
Ventricular Dysfunction, Right
1
2010
18
0.050
Why?
Electrophysiology
1
2011
247
0.050
Why?
Dose-Response Relationship, Drug
3
1973
1117
0.050
Why?
Pilot Projects
1
2012
442
0.050
Why?
Cardiopulmonary Bypass
1
1990
47
0.040
Why?
Postoperative Complications
1
1995
733
0.040
Why?
Evidence-Based Medicine
1
2012
202
0.040
Why?
Oocytes
1
2011
135
0.040
Why?
Amiodarone
1
1989
10
0.040
Why?
Fibrinolysis
1
1989
47
0.040
Why?
Xenopus laevis
1
2011
167
0.040
Why?
Carnitine
1
1989
14
0.040
Why?
Pulmonary Wedge Pressure
1
1989
7
0.040
Why?
Protein Structure, Secondary
1
2009
86
0.040
Why?
Heart Septum
1
1989
14
0.040
Why?
Papillary Muscles
1
1989
21
0.040
Why?
Obesity, Morbid
1
2010
50
0.040
Why?
Endpoint Determination
1
2009
31
0.040
Why?
Catheterization, Swan-Ganz
1
1989
13
0.040
Why?
Thrombolytic Therapy
1
1989
65
0.040
Why?
Embolization, Therapeutic
1
1989
39
0.040
Why?
Computer Simulation
1
2011
302
0.040
Why?
Pulmonary Artery
1
1989
86
0.040
Why?
Computational Biology
1
2009
67
0.040
Why?
Multicenter Studies as Topic
1
2008
129
0.040
Why?
Frameshift Mutation
1
2007
22
0.040
Why?
Japan
1
2007
30
0.040
Why?
Point Mutation
1
2008
172
0.040
Why?
RNA Splice Sites
1
2007
17
0.040
Why?
Netherlands
1
2007
29
0.040
Why?
Peptides
2
1992
285
0.040
Why?
Isoenzymes
2
1986
439
0.040
Why?
Ligands
1
2008
288
0.040
Why?
Mutagenesis, Insertional
1
2007
53
0.040
Why?
Ion Transport
1
2007
70
0.040
Why?
Postpartum Period
1
2007
38
0.040
Why?
Cell Membrane
1
1989
482
0.040
Why?
Glutamine
1
2007
63
0.040
Why?
Aspartic Acid
1
2007
46
0.040
Why?
Arginine Vasopressin
1
1986
37
0.040
Why?
Arginine
1
2007
108
0.040
Why?
Longitudinal Studies
1
2008
395
0.040
Why?
Glutamic Acid
1
2007
97
0.030
Why?
Protein Transport
1
2007
168
0.030
Why?
Castration
2
1964
41
0.030
Why?
L-Lactate Dehydrogenase
1
1986
87
0.030
Why?
Dopamine
1
1987
198
0.030
Why?
Gestational Age
1
2007
339
0.030
Why?
Models, Biological
1
2011
1008
0.030
Why?
Ovary
2
1964
91
0.030
Why?
Amino Acid Sequence
1
2009
1195
0.030
Why?
Gliadin
1
2005
2
0.030
Why?
Protein Structure, Tertiary
1
2007
347
0.030
Why?
New York
1
2009
1305
0.030
Why?
Immunoglobulin A
1
2005
90
0.030
Why?
Costs and Cost Analysis
1
2005
90
0.030
Why?
Survivors
1
2006
118
0.030
Why?
Muscles
1
1986
328
0.030
Why?
Hematocrit
2
1974
112
0.030
Why?
Purinergic P2 Receptor Antagonists
1
2004
15
0.030
Why?
Platelet Aggregation
1
2004
66
0.030
Why?
Biotransformation
1
2004
113
0.030
Why?
Transglutaminases
1
2005
62
0.030
Why?
Adenosine Diphosphate
1
2004
97
0.030
Why?
Epinephrine
1
2004
141
0.030
Why?
Aspirin
1
2004
59
0.030
Why?
Drug Resistance
1
2004
102
0.030
Why?
Molecular Sequence Data
1
2009
1988
0.030
Why?
Hypercholesterolemia
1
2004
50
0.030
Why?
Testosterone
1
1964
158
0.030
Why?
Naval Medicine
1
2003
1
0.030
Why?
Submarine Medicine
1
2003
2
0.030
Why?
Erythrocyte Indices
1
2003
10
0.030
Why?
Erythrocyte Count
1
2003
28
0.030
Why?
ROC Curve
1
2003
126
0.030
Why?
Physical Fitness
1
2003
24
0.030
Why?
Hemoglobins
1
2003
95
0.030
Why?
Immunoglobulin G
1
2005
488
0.030
Why?
Menarche
1
1982
5
0.030
Why?
Blood Glucose
1
2004
464
0.030
Why?
Mass Screening
1
2005
247
0.030
Why?
Biomedical Research
1
1964
139
0.030
Why?
Tomography, Emission-Computed, Single-Photon
1
2002
70
0.020
Why?
Statistics as Topic
1
2002
185
0.020
Why?
Body Weight
1
1982
327
0.020
Why?
Algorithms
1
2005
541
0.020
Why?
Insulin
1
2004
668
0.020
Why?
Neoplasm Metastasis
3
1964
228
0.020
Why?
Catecholamines
2
1989
79
0.020
Why?
Neoplasms
1
1964
739
0.020
Why?
Remission, Spontaneous
2
1973
47
0.020
Why?
Evaluation Studies as Topic
2
1973
245
0.020
Why?
HLA-DQ alpha-Chains
1
1995
1
0.020
Why?
HLA-DQ beta-Chains
1
1995
2
0.020
Why?
Haplotypes
1
1995
63
0.020
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
1995
33
0.020
Why?
Histidine
1
1995
48
0.020
Why?
Disease Susceptibility
1
1995
79
0.020
Why?
Leucine
1
1995
107
0.020
Why?
Myosins
1
1995
24
0.020
Why?
Body Surface Area
1
1994
12
0.020
Why?
Alleles
1
1995
205
0.020
Why?
Aortic Valve
1
1994
24
0.020
Why?
Blood Flow Velocity
1
1995
129
0.020
Why?
Reoperation
1
1995
183
0.020
Why?
Ultrasonography, Doppler, Color
1
1995
75
0.010
Why?
Thallium Radioisotopes
1
1993
14
0.010
Why?
Selection Bias
1
1993
16
0.010
Why?
Ketosteroids
1
1973
1
0.010
Why?
Vibration
1
1993
53
0.010
Why?
Radioligand Assay
1
1992
47
0.010
Why?
Neoplasm Recurrence, Local
1
1974
288
0.010
Why?
Base Sequence
1
1995
1683
0.010
Why?
HLA-DR4 Antigen
1
1990
2
0.010
Why?
Dihydroalprenolol
1
1990
3
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
1992
462
0.010
Why?
Sodium Fluoride
1
1990
68
0.010
Why?
HLA Antigens
1
1990
99
0.010
Why?
Reflex, Abnormal
1
1989
15
0.010
Why?
Emergencies
1
1989
81
0.010
Why?
Clinical Protocols
1
1989
106
0.010
Why?
Vagus Nerve
1
1989
40
0.010
Why?
Infusions, Intravenous
1
1989
143
0.010
Why?
Binding Sites
1
1991
690
0.010
Why?
Heparin
1
1990
122
0.010
Why?
Liver
1
1973
877
0.010
Why?
Electroencephalography
1
1989
176
0.010
Why?
Vascular Resistance
1
1986
80
0.010
Why?
Mechlorethamine
1
1964
9
0.010
Why?
Pleural Effusion
1
1964
31
0.010
Why?
Drainage
1
1964
56
0.010
Why?
Pleural Neoplasms
1
1964
18
0.010
Why?
Toxicology
1
1964
44
0.010
Why?
Ovarian Neoplasms
1
1964
106
0.010
Why?
Lymphoma
1
1964
162
0.010
Why?
Lung Neoplasms
1
1964
439
0.010
Why?
17-Ketosteroids
1
1974
8
0.000
Why?
Mastectomy
1
1974
43
0.000
Why?
Estrogens
1
1974
95
0.000
Why?
Lymphatic Metastasis
1
1974
142
0.000
Why?
Blood Vessels
1
1974
92
0.000
Why?
Glucocorticoids
1
1974
162
0.000
Why?
Lymph Nodes
1
1974
206
0.000
Why?
Palliative Care
1
1974
159
0.000
Why?

Visualizations


Goldenberg's Networks

Concepts
_
Co-Authors
_
Same Department